SK Capital Partners has completed the acquisition of Lisi Group’s Medical division. The business relocated its headquarters to Big Lake, Minn. and has been renamed Precera Medical.

The transaction, which was first announced in July, closed on October 31.

Precera marks its emergence as a contract development and manufacturing organization (CDMO) partner for blue chip medical device OEMs and innovators. As part of the transaction, Lisi Group kept a minority stake in the company.

Precera is a CDMO focused on producing high-precision components and assemblies for medical device OEMs. The company turns complex designs into reliable, manufacturable solutions for surgical robotics, minimally invasive surgery, orthopedics, and interventional therapies. It has four manufacturing sites: two in Minnesota and two in France, with expertise in development, rapid prototyping, precision machining, precision forging, and automated production.

The company also grew its executive leadership team by appointing CDMO industry veteran Dylan Hushka as CEO. Hushka was most recently president of DuPoint’s healthcare CDMO business and has held C-level, executive, commercial, and engineering roles at Spectrum Plastics Group, Nordson Medical, Vention Medical, IMDS, and Covidien (Medtronic). He was most recently CFO at Worldwide Clinical Trials and previously partnered with SK Capital as CFO of its prior portfolio companies Perimeter Solutions and Halo Pharmaceuticals.

“I am proud to join the Precera Medical team and, as a former customer, have been impressed by Precera’s world-class engineering, manufacturing, automation, quality assurance, and customer focus,” Huska told the press. “With more than 75 years of contract development and manufacturing excellence, Precera continues to innovate and invest in enabling market-leading medical device OEMs to launch breakthrough technologies that impact millions of patients each year. This is a new era of precision manufacturing defined by speed, reliability, and uncompromising quality. I am excited to lead the team as we establish Precera Medical as a thriving, independent company and continue to be a true strategic extension of our customers’ teams to drive improved patient outcomes.”

In connection with the closing, Precera formed an advisory board including several experienced industry leaders:

• Chris Qualters, current SK capital operating director, former CEO of TekniPlex Healthcare and former EVP of Life Sciences for NN Inc.
• Art Burghouwt, former EVP of sales, marketing, and Business Development at Tecomet
• Brian Hutchison, former CEO of Raumedic U.S. and former CEO of RTI Surgical
• Aaron Davenport, managing director at SK Capital
• Josh Lieberman, principal at SK Capital
• Emmanuel Viellard, CEO of LISI Group